Literature DB >> 27626646

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Hampig Raphael Kourie1, Marianne Paesmans2, Jean Klastersky3.   

Abstract

Keywords:  biomarkers; checkpoint inhibitors; cytokines; eosinophils; genetic predisposition; prediction; toxicity

Mesh：

Substances：

Year:  2016        PMID： 27626646     DOI： 10.2217/bmm-2016-0211

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  3 in total

1.  Infiltration of metastatic lymph nodes with PD-1+ T cells is associated with improved disease-free and overall survival in resected N+ NSCLC.

Authors:  Shuo Wang; Yuguang Song; Michael A Morse; Pingping Sun; Guoliang Qiao; Xiaoli Wang; Xinna Zhou; Amy Hobeika; Jun Ren; Herbert Kim Lyerly
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 2.  Informatics for cancer immunotherapy.

Authors:  J Hammerbacher; A Snyder
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

Review 3.  Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.

Authors:  Ronald Anderson; Bernardo L Rapoport
Journal:  Front Oncol       Date:  2018-03-22       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.